Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-22-022009

Director acquired 1,438 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
INGRAM ROBERT ALEXANDER Director 2022-08-31 Grant or award +1,438 $13.90 $19,988 96,442 D: show line 1 in the form
Loading xslF345X03/form4.xml…